Brief: Iterum Therapeutics Reports Q1 2023 Financial Results

Iterum Therapeutics

12/05/2023 13:16

May 12 (Reuters) - Iterum Therapeutics PLC  ITRM.O :
    * ITERUM THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
    * ITERUM THERAPEUTICS - EXPECTS CURRENT CASH, CASH
EQUIVALENTS AND
SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND ITS OPERATIONS
UNTIL MID-2024
    * ITERUM THERAPEUTICS PLC QTRLY NET LOSS PER SHARE - BASIC
AND
DILUTED $0.78
    * ITERUM THERAPEUTICS PLC QTRLY NON-GAAP NET LOSS PER SHARE
-
BASIC AND DILUTED $0.58

Source text for Eikon:  ID:nGNXbTsqn8 
Further company coverage:  ITRM.O 

 ((Reuters.Briefs@thomsonreuters.com;))